Joint Formulary & PAD

Imiquimod - Actinic keratosis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Cream
Associated Icons :
SPC
Restrictions / Comments :
Important

Imiquimod 5% cream

Primary care iniatiation only on recommendation from dermatology specialist team.

 

Status 2

Non Formulary
Formulations :
  • Cream
Associated Icons :
NFD1
SPC
Restrictions / Comments :
Important

Imiquimod 3.75% cream (Zyclara) - not to be prescribed. The 5% cream is a more cost-effective option.

PAD Profile

ChemicalSubstance :
Imiquimod
Indication :
Actinic keratosis
Group Name :
Keywords :
Brand Names Include :
Aldara
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Imiquimod is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Actinic keratosis.

Committee Recommendations (1)

Imiquimod 5% should only be initiated on specialist advice.

The APC has made recommendations for the primary care treatment choices for actinic keratosis - see treatment guidelines